This site is intended for healthcare professionals only

Diabetes &
Primary Care


Share this article

PCDS statement: Managing the temporary shortage of NovoRapid FlexPen devices

Hannah Beba
Publisher’s note: This supply shortage has now been resolved and stocks have stabilised. Future orders are expected to arrive in the UK as planned through to the end of the year and beyond.

Advice on switching to alternative devices or insulins during the temporary shortage.

The NovoRapid® FlexPen® will be out of stock until 21 November 2022. It is advised that healthcare professionals DO NOT initiate any new patients on NovoRapid FlexPen during this time. This shortage is likely to be emotive and may result in people accessing healthcare providers for advice during this time. Where possible, allay fears. If someone is already on NovoRapid FlexPen and is concerned that they do not have enough supply to last the next two weeks, then follow the steps below.

Helpful resource

How to calculate the amount of insulin to prescribe per month

Click here to access

Related content
Editorial: Updated guidance on prescribing incretin-based therapy, cardiovascular risk reduction and the wider uptake of CGM
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals


By clicking ‘Subscribe’, you are agreeing that are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.